AU6085500A - A lung cancer associated retrovirus, gene delivery vector and methods of use thereof - Google Patents

A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Info

Publication number: AU6085500A
Authority: AU; Australia
Prior art keywords: methods; lung cancer; gene delivery; cancer associated; delivery vector
Prior art date: 1999-07-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU60855/00A

Inventor

Hung Y. Fan

Massimo Palmarini

James M. Sharp

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California

Original Assignee

University of California

University of California Berkeley

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-08

Filing date

2000-07-08

Publication date

2001-01-30

2000-07-08 Application filed by University of California, University of California Berkeley filed Critical University of California

2001-01-30 Publication of AU6085500A publication Critical patent/AU6085500A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
- C12N2740/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
- C12N2740/12041—Use of virus, viral particle or viral elements as a vector
- C12N2740/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Immunology (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU60855/00A 1999-07-08 2000-07-08 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof Abandoned AU6085500A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US14286899P	1999-07-08	1999-07-08
US60142868		1999-07-08
PCT/US2000/018856 WO2001004266A1 (en)	1999-07-08	2000-07-08	A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Publications (1)

Publication Number	Publication Date
AU6085500A true AU6085500A (en)	2001-01-30

Family

ID=22501614

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU60855/00A Abandoned AU6085500A (en)	1999-07-08	2000-07-08	A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Country Status (3)

Country	Link
AU (1)	AU6085500A (en)
GB (1)	GB2368846B (en)
WO (1)	WO2001004266A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9969980B2 (en) *	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US7608449B2 (en)	2003-05-14	2009-10-27	The Regents Of The University Of California	Methods and compositions related to high-titer pseudotyped retroviruses
WO2010002937A1 (en)	2008-06-30	2010-01-07	Tocagen Inc.	Formulations of 5-fluorocytosine and uses thereof
CN102227503B (en)	2008-09-26	2015-10-21	托卡根公司	Recombinant vectors
US8829173B2 (en)	2008-09-26	2014-09-09	Tocagen Inc.	Recombinant vectors
WO2012058673A2 (en)	2010-10-31	2012-05-03	Tocagen Inc.	Enhanced cancer treatment and monitoring using recombinant vectors
ES2786051T3 (en) *	2012-10-25	2020-10-08	Tocagen Inc	Retroviral vector with mini-promoter cassette
US9642921B2 (en)	2012-12-20	2017-05-09	Tocagen Inc.	Cancer combination therapy and recombinant vectors
CA2943640A1 (en)	2014-03-26	2015-10-01	Tocagen Inc.	A retroviral vector having immune-stimulating activity
CA2996797A1 (en)	2015-09-04	2017-03-09	Tocagen Inc.	Recombinant vectors comprising 2a peptide
CN115433719B (en) *	2022-10-10	2024-10-18	吉林大学	Sheep-derived immortalized cell line for preparing various viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2676455A1 (en) *	1991-05-17	1992-11-20	Inst Nat Sante Rech Med	Retrovirus JSRV - Nucleic acid and proteins characteristic of this retrovirus - their applications in diagnosis and therapy
GB9425600D0 (en) *	1994-12-19	1995-02-15	Medical Res Council	Targeting complexes and use thereof
US5858990A (en) *	1997-03-04	1999-01-12	St. Elizabeth's Medical Center	Fas ligand compositions for treatment of proliferative disorders

2000
- 2000-07-08 GB GB0203028A patent/GB2368846B/en not_active Expired - Fee Related
- 2000-07-08 AU AU60855/00A patent/AU6085500A/en not_active Abandoned
- 2000-07-08 WO PCT/US2000/018856 patent/WO2001004266A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2001004266A9 (en)	2002-09-12
WO2001004266A1 (en)	2001-01-18
GB2368846A (en)	2002-05-15
GB0203028D0 (en)	2002-03-27
GB2368846B (en)	2004-08-25

Publication	Publication Date	Title
AU3395900A (en)	2000-10-04	Human lung cancer associated gene sequences and polypeptides
AUPR894201A0 (en)	2001-12-13	Respiratory delivery for gene therapy and lentiviral delivery particle
AU1409801A (en)	2001-05-30	Powder inhaler
AU5266698A (en)	1998-06-22	Directional drug delivery stent
AU2466299A (en)	1999-08-09	A new human tumor-associated gene
AU2002246925A1 (en)	2002-07-30	Therapeutic delivery balloon
AU2001264559A1 (en)	2001-12-17	Cancer gene determination and therapeutic screening using signature gene sets
WO2003002142A8 (en)	2003-12-11	Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes
AU4139801A (en)	2001-06-12	Controlled delivery of antigens
AU4803500A (en)	2000-12-18	Aerosol inhalation device providing improved aerosol delivery
AU6085500A (en)	2001-01-30	A lung cancer associated retrovirus, gene delivery vector and methods of use thereof
AU4717299A (en)	2000-01-17	Nasal delivery of sildenafil citrate
AU2637100A (en)	2000-08-25	Delivery system and methods for gene therapy
AU2001280576A1 (en)	2002-01-30	Tissue-specific self-inactivating gene therapy vector
AU2001295483A1 (en)	2002-03-13	Solid peptide preparations for inhalation, and the production thereof
AU4089899A (en)	1999-12-06	Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
AU4096100A (en)	2000-11-10	Pseudotyped retroviral vector for gene therapy of cancer
AU6503399A (en)	2001-05-10	Drug delivery catheter
AU2732000A (en)	2000-08-01	Reverse gene therapy
AU2400401A (en)	2001-07-03	Novel phosphodiesterases and genes thereof
AU2001260465A1 (en)	2001-12-11	Ubiquitin promoter in vectors for gene therapy in respiratory tract
AU1894601A (en)	2001-07-03	Novel gene and use thereof
AU5088600A (en)	2000-12-28	Gene therapy products
GB0025890D0 (en)	2000-12-06	Gene therapy
AU2669301A (en)	2001-06-25	Inhalation delivery apparatus and method

Legal Events

Date	Code	Title	Description
2002-04-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase